FDA safety policy post
Executive Summary
Director of FDA's Office of Pharmacoepidemiology & Statistical Science Paul Seligman will serve as the agency's new associate director for safety policy & communications starting in mid-May. One area of focus for the new associate director will be the implementation of an FDA drug safety bulletin that will be distributed to the public on a regular basis. He also will oversee the Drug Safety Oversight Board and the MedWatch program. Seligman's former position is being eliminated as part of an agency reorganization (1"The Pink Sheet" Nov. 7, 2005, p. 3)...